J&J(JNJ) - 2023 Q4 - Earnings Call Presentation
J&J(JNJ)2024-01-23 18:15Johnson & Johnson Innovative Medicine Pipeline Key Events in 2024* POTENTIAL APPROVALS US/EU PLANNED SUBMISSIONS US/EU POTENTIAL CLINICAL DATA SSSuuummm ooofff PRCrehogegicorkan mC Ch hCaahnnaggneege SSSuuummm ooofff PRCrehogegicorkan mC Ch hCaahnnaggneege SSSuuuPmmmh oaoosfff e PRC rIehIogIegicorkan mC Ch hCaahnnaggneege OPSUMIT (macitentan) US OPSUMIT (macitentan) US SIMPONI (golimumab) TREMFYA (guselkumab) EU Pediatric Pulmonary Arterial Hypertension Pediatric Pulmonary Arterial Hypertension EU Pediatric ...